Pakistan's neonatal and under-five mortality rates remain among the highest in South Asia. This challenge is exacerbated by a critical shortage of paediatric intensive care staff, with <30 trained specialists serving >80 million children. Recent national data indicate that only 70% of accredited paediatric hospitals have functional paediatric intensive care units, and nearly half lack adequate nurse-to-patient ratios. These shortages are most severe in rural regions, where delayed access to life-saving interventions contributes to preventable deaths. Emerging solutions such as telemedicine, neonatal care units within general hospitals, and public-private partnerships demonstrate potential for scalable reform. Strengthening paediatric critical care is essential to achieving Sustainable Development Goal 3.2 and ending preventable child deaths by 2030.
{"title":"No bed for a dying child: the shortage of paediatric intensive care in Pakistan.","authors":"Aqsa Elle, Muhammad Hamza Shafiq","doi":"10.7189/jogh.16.03003","DOIUrl":"10.7189/jogh.16.03003","url":null,"abstract":"<p><p>Pakistan's neonatal and under-five mortality rates remain among the highest in South Asia. This challenge is exacerbated by a critical shortage of paediatric intensive care staff, with <30 trained specialists serving >80 million children. Recent national data indicate that only 70% of accredited paediatric hospitals have functional paediatric intensive care units, and nearly half lack adequate nurse-to-patient ratios. These shortages are most severe in rural regions, where delayed access to life-saving interventions contributes to preventable deaths. Emerging solutions such as telemedicine, neonatal care units within general hospitals, and public-private partnerships demonstrate potential for scalable reform. Strengthening paediatric critical care is essential to achieving Sustainable Development Goal 3.2 and ending preventable child deaths by 2030.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"03003"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: This meta-analysis aims to determine the clinical manifestations, prevalence, and risk factors of asthenopia across diverse populations.
Methods: We systematically searched PubMed up to April 2024 for studies published within the last five years on asthenopia, without language or design restrictions. Reference lists were also reviewed. The study quality was evaluated using the Newcastle-Ottawa Scale. A random-effects meta-analysis was conducted to calculate proportions, prevalence rates, odds ratios (ORs) and their 95% confidence intervals (CIs).
Results: Overall, 63 studies were included. The pooled prevalence of asthenopia detected via questionnaires or symptom report was 51% (95% CI = 50%, 52%). Subgroup analyses showed high prevalence among digital device users (90%) and computer workers (77%). During the COVID-19 pandemic, prevalence rose among adults (39%-45%), university students (36%-57%), and school-aged children (45%-64%). The most frequent ocular symptoms were eye tiredness (65%, 95% CI = 46%, 84%), eye strain (47%, 95% CI = 37%, 58%), and burning/irritation (43%, 95% CI = 35%, 51%). Musculoskeletal symptoms, including neck pain (45%, 95% CI = 28%, 62%) and shoulder pain (30%, 95% CI = 12%, 48%) were also prevalent. Neuropsychological symptoms included headache (50%, 95% CI = 41%, 59%) and difficulty concentrating (44%, 95% CI = 32%, 56%). Risk factors included short sleep duration (OR = 1.28; 95% CI = 1.04, 1.57), prior eye disease (OR = 2.59; 95% CI = 1.43, 4.69), prolonged screen time (OR = 1.15; 95% CI = 1.09, 1.21), and ambient conditions like air conditioning use (OR = 23.02; 95% CI = 4.94, 107.18). Protective measures included anti-glare filters (OR = 0.34; 95% CI = 0.19, 0.64), regular breaks (OR = 0.21; 95% CI = 0.09, 0.51), and computer use knowledge (OR = 0.20; 95% CI = 0.13, 0.30).
Conclusions: Asthenopia is prevalent across diverse populations, characterised by a wide range of symptoms and influenced by modifiable risk factors. Our findings support a unified definition to improve clinical recognition and offer preliminary evidence to help shape future research on preventive strategies.
Registration: PROSPERO: CRD42024536841.
背景:本荟萃分析旨在确定不同人群中视疲劳的临床表现、患病率和危险因素。方法:我们系统地检索PubMed截至2024年4月的近五年内发表的有关视疲劳的研究,没有语言或设计限制。还审查了参考书目。研究质量采用纽卡斯尔-渥太华量表进行评估。进行随机效应荟萃分析以计算比例、患病率、优势比(ORs)及其95%置信区间(ci)。结果:共纳入63项研究。通过问卷调查或症状报告检测到的弱视总患病率为51% (95% CI = 50%, 52%)。亚组分析显示,数字设备使用者(90%)和计算机工作者(77%)的患病率较高。在2019冠状病毒病大流行期间,成年人(39%-45%)、大学生(36%-57%)和学龄儿童(45%-64%)的患病率均有所上升。最常见的眼部症状是眼疲劳(65%,95% CI = 46%, 84%)、眼疲劳(47%,95% CI = 37%, 58%)和灼烧/刺激(43%,95% CI = 35%, 51%)。肌肉骨骼症状,包括颈部疼痛(45%,95% CI = 28%, 62%)和肩部疼痛(30%,95% CI = 12%, 48%)也很普遍。神经心理症状包括头痛(50%,95% CI = 41%, 59%)和注意力难以集中(44%,95% CI = 32%, 56%)。危险因素包括睡眠时间短(OR = 1.28; 95% CI = 1.04, 1.57)、既往眼病(OR = 2.59; 95% CI = 1.43, 4.69)、长时间看屏幕(OR = 1.15; 95% CI = 1.09, 1.21)和使用空调等环境条件(OR = 23.02; 95% CI = 4.94, 107.18)。防护措施包括防眩光滤光片(OR = 0.34; 95% CI = 0.19, 0.64)、定期休息(OR = 0.21; 95% CI = 0.09, 0.51)和电脑使用知识(OR = 0.20; 95% CI = 0.13, 0.30)。结论:视疲劳在不同人群中普遍存在,其特点是症状范围广泛,并受到可改变的危险因素的影响。我们的研究结果支持一个统一的定义,以提高临床认识,并提供初步证据,以帮助塑造未来的预防策略研究。报名:普洛斯彼罗:CRD42024536841。
{"title":"Clinical manifestations, prevalence, and risk factors of asthenopia: a systematic review and meta-analysis.","authors":"Fan Song, Yanjun Liu, Ziwei Zhao, Xianwen Shang, Yueye Wang, Mengying Lai, Mingguang He, Yanxian Chen","doi":"10.7189/jogh.16.04053","DOIUrl":"10.7189/jogh.16.04053","url":null,"abstract":"<p><strong>Background: </strong>This meta-analysis aims to determine the clinical manifestations, prevalence, and risk factors of asthenopia across diverse populations.</p><p><strong>Methods: </strong>We systematically searched PubMed up to April 2024 for studies published within the last five years on asthenopia, without language or design restrictions. Reference lists were also reviewed. The study quality was evaluated using the Newcastle-Ottawa Scale. A random-effects meta-analysis was conducted to calculate proportions, prevalence rates, odds ratios (ORs) and their 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Overall, 63 studies were included. The pooled prevalence of asthenopia detected via questionnaires or symptom report was 51% (95% CI = 50%, 52%). Subgroup analyses showed high prevalence among digital device users (90%) and computer workers (77%). During the COVID-19 pandemic, prevalence rose among adults (39%-45%), university students (36%-57%), and school-aged children (45%-64%). The most frequent ocular symptoms were eye tiredness (65%, 95% CI = 46%, 84%), eye strain (47%, 95% CI = 37%, 58%), and burning/irritation (43%, 95% CI = 35%, 51%). Musculoskeletal symptoms, including neck pain (45%, 95% CI = 28%, 62%) and shoulder pain (30%, 95% CI = 12%, 48%) were also prevalent. Neuropsychological symptoms included headache (50%, 95% CI = 41%, 59%) and difficulty concentrating (44%, 95% CI = 32%, 56%). Risk factors included short sleep duration (OR = 1.28; 95% CI = 1.04, 1.57), prior eye disease (OR = 2.59; 95% CI = 1.43, 4.69), prolonged screen time (OR = 1.15; 95% CI = 1.09, 1.21), and ambient conditions like air conditioning use (OR = 23.02; 95% CI = 4.94, 107.18). Protective measures included anti-glare filters (OR = 0.34; 95% CI = 0.19, 0.64), regular breaks (OR = 0.21; 95% CI = 0.09, 0.51), and computer use knowledge (OR = 0.20; 95% CI = 0.13, 0.30).</p><p><strong>Conclusions: </strong>Asthenopia is prevalent across diverse populations, characterised by a wide range of symptoms and influenced by modifiable risk factors. Our findings support a unified definition to improve clinical recognition and offer preliminary evidence to help shape future research on preventive strategies.</p><p><strong>Registration: </strong>PROSPERO: CRD42024536841.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04053"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jun-Han Wei, Yi-Ming Guo, Jia-Qi Wang, Yi-Jin Han, Qian Yao, Guo-Yun Zhang, Lu Ye
Background: Astigmatism is a common refractive error in children and adolescents. This study aimed to investigate the prevalence, severity, types, correction status, and associated risk factors of astigmatism among children and adolescents in Shaanxi Province, China.
Methods: A cross-sectional study was conducted involving 236 397 children and adolescents aged 3-20 years from Shaanxi Province, selected through multistage stratified cluster random sampling. Demographic information was gathered via structured questionnaires, and refractive status was assessed using an autorefractor without cycloplegia. Astigmatism was defined as cylindrical refractive error ≥0.50 dioptres.
Results: The overall prevalence of astigmatism was 73.81% among the studied population. Age showed a clear positive association with prevalence, which was significantly higher in adolescents compared to younger children. Similar patterns were observed across advancing educational levels. Males showed slightly higher prevalence than females. Geographic distribution revealed a north-to-south gradient, with northern regions having the highest prevalence. Regarding astigmatism types, with-the-rule astigmatism and compound myopic astigmatism were the predominant forms. Only 30.73% of affected subjects had received refractive correction, with correction rates markedly increasing with age and educational level. Multivariate analyses confirmed that older age, higher educational attainment, male gender, northern residence, and non-Han ethnicity were independent risk factors for astigmatism.
Conclusions: Astigmatism prevalence among children in Shaanxi Province is considerably higher than previously reported in other Chinese regions, with significant variations across demographic factors. The low correction rate, particularly among younger children, highlights the need for enhanced early screening and timely intervention programmes to prevent visual function impairment.
{"title":"Characterisation and risk factors of astigmatism among children and adolescents aged 3-20 years in Northwestern China.","authors":"Jun-Han Wei, Yi-Ming Guo, Jia-Qi Wang, Yi-Jin Han, Qian Yao, Guo-Yun Zhang, Lu Ye","doi":"10.7189/jogh.16.04047","DOIUrl":"10.7189/jogh.16.04047","url":null,"abstract":"<p><strong>Background: </strong>Astigmatism is a common refractive error in children and adolescents. This study aimed to investigate the prevalence, severity, types, correction status, and associated risk factors of astigmatism among children and adolescents in Shaanxi Province, China.</p><p><strong>Methods: </strong>A cross-sectional study was conducted involving 236 397 children and adolescents aged 3-20 years from Shaanxi Province, selected through multistage stratified cluster random sampling. Demographic information was gathered via structured questionnaires, and refractive status was assessed using an autorefractor without cycloplegia. Astigmatism was defined as cylindrical refractive error ≥0.50 dioptres.</p><p><strong>Results: </strong>The overall prevalence of astigmatism was 73.81% among the studied population. Age showed a clear positive association with prevalence, which was significantly higher in adolescents compared to younger children. Similar patterns were observed across advancing educational levels. Males showed slightly higher prevalence than females. Geographic distribution revealed a north-to-south gradient, with northern regions having the highest prevalence. Regarding astigmatism types, with-the-rule astigmatism and compound myopic astigmatism were the predominant forms. Only 30.73% of affected subjects had received refractive correction, with correction rates markedly increasing with age and educational level. Multivariate analyses confirmed that older age, higher educational attainment, male gender, northern residence, and non-Han ethnicity were independent risk factors for astigmatism.</p><p><strong>Conclusions: </strong>Astigmatism prevalence among children in Shaanxi Province is considerably higher than previously reported in other Chinese regions, with significant variations across demographic factors. The low correction rate, particularly among younger children, highlights the need for enhanced early screening and timely intervention programmes to prevent visual function impairment.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04047"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annariina Koivu, Ulla Ashorn, Elaine Borghi, Andreas Hasman, Purnima Menon, Aman Pulungan, Julie Ruel-Bergeron, Linda Shaker-Berbari, Madhumita Singh, Naveen Thacker, Wilson Milton Were, Kaisa Ylikruuvi, Per Ashorn
Background: Monitoring children's growth is crucial in paediatric care for early identification of health issues, with the World Health Organization (WHO) advocating for its practice throughout childhood. However, the focus and implementation of growth monitoring vary globally, reflecting different health priorities and practices.
Methods: We conducted a global, cross-sectional, questionnaire-based survey, targeted at representatives of the ministry responsible for growth monitoring and promotion, and at representatives of national paediatric societies.
Results: We obtained responses from 122 countries. Of these, 88% had national growth monitoring guidance, most often issued by the ministry of health. Weight was the most consistently measured early childhood growth monitoring indicator, recorded routinely in 98% of countries during growth monitoring visits for children aged <1 year. The WHO Child Growth Standards were used in 86% of countries. The most common follow-up action for growth faltering was provision of nutritional or health advice, cited by 91% of respondents for children aged <1 year, with advice frequency decreasing as child age increased.
Conclusions: Childhood growth monitoring is widely adopted, but implemented with considerable variation across countries. Strengthening its impact will require standardising indicators, integrating evidence-based guidelines into primary care, and ensuring equitable, actionable use across age groups.
{"title":"Global assessment of childhood growth monitoring: cross-sectional survey of national policies and practices.","authors":"Annariina Koivu, Ulla Ashorn, Elaine Borghi, Andreas Hasman, Purnima Menon, Aman Pulungan, Julie Ruel-Bergeron, Linda Shaker-Berbari, Madhumita Singh, Naveen Thacker, Wilson Milton Were, Kaisa Ylikruuvi, Per Ashorn","doi":"10.7189/jogh.16.04034","DOIUrl":"10.7189/jogh.16.04034","url":null,"abstract":"<p><strong>Background: </strong>Monitoring children's growth is crucial in paediatric care for early identification of health issues, with the World Health Organization (WHO) advocating for its practice throughout childhood. However, the focus and implementation of growth monitoring vary globally, reflecting different health priorities and practices.</p><p><strong>Methods: </strong>We conducted a global, cross-sectional, questionnaire-based survey, targeted at representatives of the ministry responsible for growth monitoring and promotion, and at representatives of national paediatric societies.</p><p><strong>Results: </strong>We obtained responses from 122 countries. Of these, 88% had national growth monitoring guidance, most often issued by the ministry of health. Weight was the most consistently measured early childhood growth monitoring indicator, recorded routinely in 98% of countries during growth monitoring visits for children aged <1 year. The WHO Child Growth Standards were used in 86% of countries. The most common follow-up action for growth faltering was provision of nutritional or health advice, cited by 91% of respondents for children aged <1 year, with advice frequency decreasing as child age increased.</p><p><strong>Conclusions: </strong>Childhood growth monitoring is widely adopted, but implemented with considerable variation across countries. Strengthening its impact will require standardising indicators, integrating evidence-based guidelines into primary care, and ensuring equitable, actionable use across age groups.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04034"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yinuo Sun, Jiyan Ma, Jingya Dong, Yiwu Gu, Myeong Soo Lee, Lin Ang, Yuming Liu, Yangmu Huang
Background: Traditional medicines can contribute to achieving universal health coverage, particularly in low- and middle-income countries where access to conventional treatments is limited. International collaboration is crucial to bridge the lag in modernised research and promote access to traditional medicines. This study focused on China's global collaborative research and development (R&D) efforts on traditional medicine, in the hope of improving global recognition for traditional medicine.
Methods: We conducted a cross-sectional study to analyse collaborative R&D outputs on Chinese patent medicines from 1996 to 2022. The study cohort included the collaborative outputs of scientific research, patent applications, and clinical trials between China and other countries. We analysed the outputs using data from the Web of Science, Worldwide Patent Statistical Database, and the International Clinical Trials Registry Platform. The Zero Inflated Negative Binomial regression model was employed to investigate the association between outputs and the characteristics of participating countries.
Results: The majority of collaborative outputs (n = 964, 92.4%) originated from collaborations with high-income countries, with only 7.6% involving low- and middle- income countries (LMICs). The percentage of R&D collaborations with LMICs showed an increasing trend from 0% in 1996 to 11.7% in 2022. Most collaborations focused on non-communicable diseases (n = 912, 87.4%). Low-income countries accounted for a larger share of collaborative R&D on communicable diseases (14.3%) compared with high-income countries (1.4%). The total number of outputs was positively associated with the degree of cooperative institutionalisation and the collaborator's traditional medicine development score.
Conclusions: Gaps still remain in the involvement of low- and middle-income members compared with high income countries. Findings highlight the importance of encouraging greater engagement of low- and middle- income countries in global R & D collaboration on traditional medicine, particularly through South-South partnerships. Such collaborations should prioritise research agendas that address local health priorities, especially those related to communicable diseases.
{"title":"International collaborative research and development (R&D) on traditional medicine and its contextual factors: a cross-sectional analysis from 1996 to 2022.","authors":"Yinuo Sun, Jiyan Ma, Jingya Dong, Yiwu Gu, Myeong Soo Lee, Lin Ang, Yuming Liu, Yangmu Huang","doi":"10.7189/jogh.16.04029","DOIUrl":"10.7189/jogh.16.04029","url":null,"abstract":"<p><strong>Background: </strong>Traditional medicines can contribute to achieving universal health coverage, particularly in low- and middle-income countries where access to conventional treatments is limited. International collaboration is crucial to bridge the lag in modernised research and promote access to traditional medicines. This study focused on China's global collaborative research and development (R&D) efforts on traditional medicine, in the hope of improving global recognition for traditional medicine.</p><p><strong>Methods: </strong>We conducted a cross-sectional study to analyse collaborative R&D outputs on Chinese patent medicines from 1996 to 2022. The study cohort included the collaborative outputs of scientific research, patent applications, and clinical trials between China and other countries. We analysed the outputs using data from the Web of Science, Worldwide Patent Statistical Database, and the International Clinical Trials Registry Platform. The Zero Inflated Negative Binomial regression model was employed to investigate the association between outputs and the characteristics of participating countries.</p><p><strong>Results: </strong>The majority of collaborative outputs (n = 964, 92.4%) originated from collaborations with high-income countries, with only 7.6% involving low- and middle- income countries (LMICs). The percentage of R&D collaborations with LMICs showed an increasing trend from 0% in 1996 to 11.7% in 2022. Most collaborations focused on non-communicable diseases (n = 912, 87.4%). Low-income countries accounted for a larger share of collaborative R&D on communicable diseases (14.3%) compared with high-income countries (1.4%). The total number of outputs was positively associated with the degree of cooperative institutionalisation and the collaborator's traditional medicine development score.</p><p><strong>Conclusions: </strong>Gaps still remain in the involvement of low- and middle-income members compared with high income countries. Findings highlight the importance of encouraging greater engagement of low- and middle- income countries in global R & D collaboration on traditional medicine, particularly through South-South partnerships. Such collaborations should prioritise research agendas that address local health priorities, especially those related to communicable diseases.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04029"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Stress-related sleep disturbance have become a serious public health problem among adolescents worldwide. There is a paucity of research employing standardised methodologies to evaluate the association between sedentary behaviour, physical activity, and stress-related sleep disturbance among adolescents. We aimed to examine the association between sedentary behaviour and/or physical activity with stress-related sleep disturbance among adolescents worldwide.
Methods: We used data from the Global School-based Student Health Survey (GSHS) conducted from 2010 to 2019, encompassing 275 483 adolescents aged 12-17 years across 69 countries. Multi-variable logistic regression analysis was performed to assess the independent and joint effect of sedentary behaviour and physical activity on stress-related sleep disturbance.
Results: 30.0% of adolescents spend ≥2 hours in sedentary behaviour daily, only 15.4% engage in physical activity for over one hour each day, and 8.3% of adolescents suffer from stress-related sleep disturbances. Compared with those who engaged sedentary behaviour <2 hours/day, 3-4 hours (odds ratio (OR) = 1.168; 95% CI = 1.027-1.329), 5-6 hours (OR = 1.413; 95% CI = 1.169-1.707), and ≥7 hours (OR = 1.792; 1.548-2.076) of daily sedentary behaviour are positively associated with stress-related sleep disturbances among adolescents. Compared with adolescents with low sedentary behaviour and sufficient physical activity, adolescents with low sedentary behaviour and insufficient physical activity (OR = 1.303; 95% CI = 1.052-1.615), high sedentary behaviour and insufficient physical activity (OR = 1.666; 95% CI = 1.350-2.056), and adolescents with high sedentary behaviour and sufficient physical activity (OR = 1.852; 95% CI = 1.432-2.396) are positively associated with stress-related sleep disturbance.
Conclusions: Sedentary behaviour is associated with a higher risk of stress-related sleep disturbances among adolescents. Reducing sedentary behaviour time may serve as a potential intervention strategy for addressing stress-related sleep disturbances, while the potential benefits of increasing physical activity require further research and validation.
{"title":"Associations of sedentary behaviour and physical activity with stress-related sleep disturbance among adolescents in 69 countries: a population-based study.","authors":"Jingpeng Li, Yongliang Zhu, Danyi Huang, Mengna Pan, Fei Li, Liuqing Li, Jiahong Sun, Chuanwei Ma, Bingsong Zhang","doi":"10.7189/jogh.16.04049","DOIUrl":"10.7189/jogh.16.04049","url":null,"abstract":"<p><strong>Background: </strong>Stress-related sleep disturbance have become a serious public health problem among adolescents worldwide. There is a paucity of research employing standardised methodologies to evaluate the association between sedentary behaviour, physical activity, and stress-related sleep disturbance among adolescents. We aimed to examine the association between sedentary behaviour and/or physical activity with stress-related sleep disturbance among adolescents worldwide.</p><p><strong>Methods: </strong>We used data from the Global School-based Student Health Survey (GSHS) conducted from 2010 to 2019, encompassing 275 483 adolescents aged 12-17 years across 69 countries. Multi-variable logistic regression analysis was performed to assess the independent and joint effect of sedentary behaviour and physical activity on stress-related sleep disturbance.</p><p><strong>Results: </strong>30.0% of adolescents spend ≥2 hours in sedentary behaviour daily, only 15.4% engage in physical activity for over one hour each day, and 8.3% of adolescents suffer from stress-related sleep disturbances. Compared with those who engaged sedentary behaviour <2 hours/day, 3-4 hours (odds ratio (OR) = 1.168; 95% CI = 1.027-1.329), 5-6 hours (OR = 1.413; 95% CI = 1.169-1.707), and ≥7 hours (OR = 1.792; 1.548-2.076) of daily sedentary behaviour are positively associated with stress-related sleep disturbances among adolescents. Compared with adolescents with low sedentary behaviour and sufficient physical activity, adolescents with low sedentary behaviour and insufficient physical activity (OR = 1.303; 95% CI = 1.052-1.615), high sedentary behaviour and insufficient physical activity (OR = 1.666; 95% CI = 1.350-2.056), and adolescents with high sedentary behaviour and sufficient physical activity (OR = 1.852; 95% CI = 1.432-2.396) are positively associated with stress-related sleep disturbance.</p><p><strong>Conclusions: </strong>Sedentary behaviour is associated with a higher risk of stress-related sleep disturbances among adolescents. Reducing sedentary behaviour time may serve as a potential intervention strategy for addressing stress-related sleep disturbances, while the potential benefits of increasing physical activity require further research and validation.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04049"},"PeriodicalIF":4.3,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ameena Goga, Trisha Ramraj, Jeané Cloete, Dini Mawela, Zainab Waggie, Moherndran Archary, Kogielambal Chinniah, Prakash Jeena, Nomakhuwa E Tabane, Riana Van Zyl, Gary Reubenson, Renate Strehlau, Ute Feucht, Tarylee Reddy, Nobuhle Mchunu, Shannon Cawood, Liesl Zühlke, Kate Webb, Heather J Zar, Kirsten A Donald, Christiaan Scott, Brenda M Morrow, Thomas Aldersley, Nicolette M du Plessis, Terusha Chetty, Sithembiso Velaphi, Ziyaad Dangor, David P Moore
Background: Knowledge gaps persist regarding paediatric COVID-19 clinical presentation, treatment and outcomes in high HIV prevalence settings, with low COVID-19 vaccine coverage.
Methods: An ambi-directional cohort study was conducted in 13 South African public sector hospitals. Hospitalised children with SARS-CoV-2 infection or post-infection syndrome were included. Main outcomes measures included severe disease and primary COVID-19 (hospitalisation for SARS-CoV-2 infection).
Results: There were 2363 SARS-CoV-2 positive children included (March 2020 through May 2023); median age 23.6 months (interquartile range (IQR) = 4.3-98.2 months). Excluding missing values, 1618 (68.9%) children had primary COVID-19; 1121 (69.3%) of these had severe primary COVID-19. In the primary COVID-19 group with data, 318 / 1588 (20.0%) received intensive or high care, 121/1285 (9.4%) received a blood transfusion and 48/1616 (3.0%) died. Multivariable analyses demonstrated that severe primary COVID-19 was 32% higher in children aged 29-365 days (adjusted Risk Ratio (aRR) = 1.32 (95% confidence interval (CI) = 1.13-1.55); reference: 0-28 days), 13% higher with one or more comorbidities (aRR = 1.13; CI = 1.05-1.22)), and 14-22% lower during the Beta, Delta and Omicron periods (reference: ancestral period). Amongst all hospitalised children with a positive SARS-CoV-2 test, severe disease was commoner in underweight children (aRR 1.09; CI = 1.02-1.17, P = 0.013)). Severe signs were commoner in children living with HIV (CLHIV), 88/121 (72.7%), vs. HIV uninfected 1320 / 2104 (62.7%), P = 0.026, and in antiretroviral therapy-naïve CLHIV, (37 / 41 (90.2%), vs. CLHIV on therapy 51 / 80 (63.8%), P = 0.002).
Conclusions: In a high HIV prevalence country, approximately 70% of children with a positive SARS-CoV-2 test were hospitalised for COVID-19 treatment; almost 70% of these children were severely ill. Controlling for other factors, disease severity was highest in the hypothesised pre-immunity Ancestral period. HIV infection and delayed ART initiation were associated with severe signs. In such settings, strengthening general child health programmes to reduce underweight and prevent or treat paediatric HIV may reduce the severity of new diseases of pandemic proportion.
{"title":"Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020-2023.","authors":"Ameena Goga, Trisha Ramraj, Jeané Cloete, Dini Mawela, Zainab Waggie, Moherndran Archary, Kogielambal Chinniah, Prakash Jeena, Nomakhuwa E Tabane, Riana Van Zyl, Gary Reubenson, Renate Strehlau, Ute Feucht, Tarylee Reddy, Nobuhle Mchunu, Shannon Cawood, Liesl Zühlke, Kate Webb, Heather J Zar, Kirsten A Donald, Christiaan Scott, Brenda M Morrow, Thomas Aldersley, Nicolette M du Plessis, Terusha Chetty, Sithembiso Velaphi, Ziyaad Dangor, David P Moore","doi":"10.7189/jogh.16.04009","DOIUrl":"10.7189/jogh.16.04009","url":null,"abstract":"<p><strong>Background: </strong>Knowledge gaps persist regarding paediatric COVID-19 clinical presentation, treatment and outcomes in high HIV prevalence settings, with low COVID-19 vaccine coverage.</p><p><strong>Methods: </strong>An ambi-directional cohort study was conducted in 13 South African public sector hospitals. Hospitalised children with SARS-CoV-2 infection or post-infection syndrome were included. Main outcomes measures included severe disease and primary COVID-19 (hospitalisation for SARS-CoV-2 infection).</p><p><strong>Results: </strong>There were 2363 SARS-CoV-2 positive children included (March 2020 through May 2023); median age 23.6 months (interquartile range (IQR) = 4.3-98.2 months). Excluding missing values, 1618 (68.9%) children had primary COVID-19; 1121 (69.3%) of these had severe primary COVID-19. In the primary COVID-19 group with data, 318 / 1588 (20.0%) received intensive or high care, 121/1285 (9.4%) received a blood transfusion and 48/1616 (3.0%) died. Multivariable analyses demonstrated that severe primary COVID-19 was 32% higher in children aged 29-365 days (adjusted Risk Ratio (aRR) = 1.32 (95% confidence interval (CI) = 1.13-1.55); reference: 0-28 days), 13% higher with one or more comorbidities (aRR = 1.13; CI = 1.05-1.22)), and 14-22% lower during the Beta, Delta and Omicron periods (reference: ancestral period). Amongst all hospitalised children with a positive SARS-CoV-2 test, severe disease was commoner in underweight children (aRR 1.09; CI = 1.02-1.17, P = 0.013)). Severe signs were commoner in children living with HIV (CLHIV), 88/121 (72.7%), vs. HIV uninfected 1320 / 2104 (62.7%), P = 0.026, and in antiretroviral therapy-naïve CLHIV, (37 / 41 (90.2%), vs. CLHIV on therapy 51 / 80 (63.8%), P = 0.002).</p><p><strong>Conclusions: </strong>In a high HIV prevalence country, approximately 70% of children with a positive SARS-CoV-2 test were hospitalised for COVID-19 treatment; almost 70% of these children were severely ill. Controlling for other factors, disease severity was highest in the hypothesised pre-immunity Ancestral period. HIV infection and delayed ART initiation were associated with severe signs. In such settings, strengthening general child health programmes to reduce underweight and prevent or treat paediatric HIV may reduce the severity of new diseases of pandemic proportion.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04009"},"PeriodicalIF":4.3,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12856961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wanyi Zheng, Guojia Jiang, Jolaoluwa Grace Oparinde, Ziqi Zhang, Deji Song, Yi Ding, Jiayun Feng, Youyan Xu, Danni Xu, Hailei Zhao, Li Zhang, Guang Ji, Lili Lu
Background: Pancreatic cancer (PC) ranks among the most lethal malignant neoplasms, primarily due to its late-stage diagnosis and lack of available therapeutic modalities. This study aimed to characterise the current PC epidemiological profiles, lifestyle-related contributors, and projections to unveil its global disease burden.
Methods: Using 2022 data from the Global Cancer Observatory (GCO), we estimated PC incidence, mortality, 5-year prevalence, and mortality-incidence-ratio. Modifiable risk factors were extracted from the Global Health Observatory to identify its predictive model. The temporal trends were assessed via estimated annual percentage changes (EAPCs) stratified by age and gender, and the future projection was also collected from GCO, 2022-2050, estimated number of new cases and deaths data.
Results: In 2022, Northern America and Europe had the highest PC burden, with males consistently affected more than females. Alarmingly, a concerning increase in PC mortality was observed among older females. Projections indicate an 85-91% increase in elderly PC cases by 2050, with Asia facing the greatest challenge (487 087 estimated new cases) and Africa being estimated with the fastest mortality growth (159.2%). Strong positive correlations were observed between PC prevalence and human development index (HDI), as well as lifestyle factors e.g. raised total cholesterol (correlation coefficient (r) = 0.695, P < 0.001), cigarette smoking (r = 0.528, P < 0.001), and alcohol drinking (r = 0.505, P < 0.001).
Conclusions: This research underlines the urgent need for region-specific interventions, not only for Northern America and Europe, which currently bear a high PC burden, but also for high-risk populations like Asia and Africa. The projected 85-91% rise in elderly PC cases by 2050, coupled with emerging risks in young females (incidence rose in n/N = 39/52 countries), demands prioritised research on modifiable factors and sex-tailored prevention strategies. These discoveries call for global action to mitigate the escalating PC burden through demographic-targeted public health measures.
背景:胰腺癌(PC)是最致命的恶性肿瘤之一,主要是由于其晚期诊断和缺乏可用的治疗方式。本研究旨在描述当前PC的流行病学概况、与生活方式相关的因素以及揭示其全球疾病负担的预测。方法:利用全球癌症观测站(GCO) 2022年的数据,我们估计了PC的发病率、死亡率、5年患病率和死亡率发病率比。从全球卫生观察站提取可修改的风险因素,以确定其预测模型。通过按年龄和性别分层的估计年百分比变化(EAPCs)来评估时间趋势,并从2022-2050年的GCO、估计新病例数和死亡数据中收集未来预测。结果:2022年,北美和欧洲的PC负担最高,男性的影响始终高于女性。令人震惊的是,在老年女性中观察到PC死亡率的增加。预测显示,到2050年,老年PC病例将增加85-91%,其中亚洲面临的挑战最大(估计新增病例为487087例),非洲的死亡率增长最快(159.2%)。PC患病率与人类发展指数(HDI)以及生活方式因素(如总胆固醇升高)之间存在显著正相关(相关系数(r) = 0.695, P)。结论:本研究表明,不仅对于目前PC负担较高的北美和欧洲,而且对于亚洲和非洲等高危人群,迫切需要采取针对特定区域的干预措施。预计到2050年,老年PC病例将增加85-91%,再加上年轻女性中出现的风险(n/ n = 39/52个国家的发病率上升),需要优先研究可改变的因素和针对性别的预防策略。这些发现要求采取全球行动,通过针对人口的公共卫生措施,减轻日益加重的个人感染负担。
{"title":"Global surge in pancreatic cancer cases driven by ageing populations and modifiable risks.","authors":"Wanyi Zheng, Guojia Jiang, Jolaoluwa Grace Oparinde, Ziqi Zhang, Deji Song, Yi Ding, Jiayun Feng, Youyan Xu, Danni Xu, Hailei Zhao, Li Zhang, Guang Ji, Lili Lu","doi":"10.7189/jogh.16.04032","DOIUrl":"10.7189/jogh.16.04032","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer (PC) ranks among the most lethal malignant neoplasms, primarily due to its late-stage diagnosis and lack of available therapeutic modalities. This study aimed to characterise the current PC epidemiological profiles, lifestyle-related contributors, and projections to unveil its global disease burden.</p><p><strong>Methods: </strong>Using 2022 data from the Global Cancer Observatory (GCO), we estimated PC incidence, mortality, 5-year prevalence, and mortality-incidence-ratio. Modifiable risk factors were extracted from the Global Health Observatory to identify its predictive model. The temporal trends were assessed via estimated annual percentage changes (EAPCs) stratified by age and gender, and the future projection was also collected from GCO, 2022-2050, estimated number of new cases and deaths data.</p><p><strong>Results: </strong>In 2022, Northern America and Europe had the highest PC burden, with males consistently affected more than females. Alarmingly, a concerning increase in PC mortality was observed among older females. Projections indicate an 85-91% increase in elderly PC cases by 2050, with Asia facing the greatest challenge (487 087 estimated new cases) and Africa being estimated with the fastest mortality growth (159.2%). Strong positive correlations were observed between PC prevalence and human development index (HDI), as well as lifestyle factors e.g. raised total cholesterol (correlation coefficient (r) = 0.695, P < 0.001), cigarette smoking (r = 0.528, P < 0.001), and alcohol drinking (r = 0.505, P < 0.001).</p><p><strong>Conclusions: </strong>This research underlines the urgent need for region-specific interventions, not only for Northern America and Europe, which currently bear a high PC burden, but also for high-risk populations like Asia and Africa. The projected 85-91% rise in elderly PC cases by 2050, coupled with emerging risks in young females (incidence rose in n/N = 39/52 countries), demands prioritised research on modifiable factors and sex-tailored prevention strategies. These discoveries call for global action to mitigate the escalating PC burden through demographic-targeted public health measures.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04032"},"PeriodicalIF":4.3,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12856964/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samantha Yoo, Azita Montazeri, Derrick Bennett, Yacong Bo, Peizhan Chen, Susan Duthie, Natalie Jensen, Atipatsa Kaminga, Jun-Shi Lai, Xue Li, Amanda J MacFarlane, Homero Martinez, Helene McNulty, Franco Momoli, Peter Mossey, Patrick Mullie, Ron Munger, Rajendra Prasad Parajuli, Monique Potvin Kent, Michele Rubini, Marjanne Senekal, Lindsey Sikora, Alain Stintzi, Evropi Theodoratou, Hui Wang, Chittaranjan Yajnik, Ann Yaktine, Julian Little
Background: Folate is essential for normal growth and in human health throughout the lifecycle. Clinical deficiency of folate impairs DNA synthesis and results in megaloblastic anaemia, while suboptimal folate status before and in early pregnancy results in an elevated risk of neural tube defects (NTD). The evidence on the association of folate status with other health outcomes is largely fragmented and understudied. We conducted a series of umbrella reviews examining the association between folate and multiple health outcomes in various populations and settings.
Methods: We searched MEDLINE, Embase, CINAHL, the Cochrane Library, and DARE from inception to February 2024 for systematic reviews with or without meta-analyses examining an association between folate intake/status and any health outcome. We performed screening and data extraction in duplicate and assessed the risk of bias using the ROBIS tool. Evidence was then characterised into unique associations (unique exposure measure - unique outcome measure - unique setting). For each category of unique associations, we identified the evidence based on the statistical power, recency of publication and the potential risk of bias. All unique associations were evaluated for credibility using predefined criteria.
Results: We retrieved 3565 records and included 283 in the final synthesis. The evidence on anaemia consisted of four intervention trials demonstrating effectiveness of folic acid supplementation during pregnancy in reducing the risk of megaloblastic anaemia (relative risk (RR) = 0.21; 95% CI = 0.11, 0.38; I2 = 15%). Maternal folic acid use was also significantly inversely related to the prevention of NTD at birth (RR = 0.31; 95% CI = 0.16, 0.60; I2 = 0%) and NTD recurrence (RR = 0.30; 95% CI = 0.14, 0.65; I2 = 0%). This relationship was supported by the inverse association reported between low maternal blood folate concentrations and the increased risk of NTD. Further evidence showed that fortification of food with folic acid was associated with the lower prevalence of NTD on a population-level.
Conclusion: In NTDs and anaemia, we identified strong evidence supporting the protective role of folate status based on intervention trials and observational studies. More recent reviews examining the role of folate in other less well understood health conditions will be presented in the subsequent reports.
Registration: PROSPERO: CRD42021265041.
背景:叶酸在整个生命周期中对正常生长和人体健康至关重要。临床叶酸缺乏会损害DNA合成并导致巨幼细胞贫血,而妊娠前和妊娠早期叶酸水平不佳会导致神经管缺陷(NTD)的风险升高。关于叶酸状况与其他健康结果之间关系的证据在很大程度上是碎片化的,研究不足。我们对不同人群和环境中叶酸与多种健康结果之间的关系进行了一系列综述。方法:我们检索了MEDLINE、Embase、CINAHL、Cochrane Library和DARE从成立到2024年2月的系统评价,有无荟萃分析检查叶酸摄入/状态与任何健康结果之间的关系。我们进行了重复筛选和数据提取,并使用ROBIS工具评估偏倚风险。然后将证据表征为独特的关联(独特的暴露测量-独特的结果测量-独特的环境)。对于每一类独特的关联,我们根据统计能力、发表的近时性和潜在的偏倚风险来确定证据。使用预定义的标准评估所有独特关联的可信度。结果:我们检索到3565条记录,最终合成了283条。有关贫血的证据包括四项干预试验,证明孕期补充叶酸可有效降低巨幼细胞贫血的风险(相对风险(RR) = 0.21;95% ci = 0.11, 0.38;i2 = 15%)。母亲叶酸的使用也与新生儿NTD的预防呈显著负相关(RR = 0.31; 95% CI = 0.16, 0.60; I2 = 0%)和NTD的复发(RR = 0.30; 95% CI = 0.14, 0.65; I2 = 0%)。这种关系得到了母体血液中叶酸浓度低与NTD风险增加呈负相关的报道的支持。进一步的证据表明,在人群水平上,叶酸强化食品与NTD患病率较低有关。结论:在NTDs和贫血中,我们根据干预试验和观察性研究发现了强有力的证据支持叶酸状态的保护作用。关于叶酸在其他不太为人所知的健康状况中的作用的最新审查将在随后的报告中提出。报名:普洛斯彼罗:CRD42021265041。
{"title":"Folate and global health umbrella review series, part 1: methodological framework and syntheses on anaemia and neural tube defects.","authors":"Samantha Yoo, Azita Montazeri, Derrick Bennett, Yacong Bo, Peizhan Chen, Susan Duthie, Natalie Jensen, Atipatsa Kaminga, Jun-Shi Lai, Xue Li, Amanda J MacFarlane, Homero Martinez, Helene McNulty, Franco Momoli, Peter Mossey, Patrick Mullie, Ron Munger, Rajendra Prasad Parajuli, Monique Potvin Kent, Michele Rubini, Marjanne Senekal, Lindsey Sikora, Alain Stintzi, Evropi Theodoratou, Hui Wang, Chittaranjan Yajnik, Ann Yaktine, Julian Little","doi":"10.7189/jogh.16.04014","DOIUrl":"10.7189/jogh.16.04014","url":null,"abstract":"<p><strong>Background: </strong>Folate is essential for normal growth and in human health throughout the lifecycle. Clinical deficiency of folate impairs DNA synthesis and results in megaloblastic anaemia, while suboptimal folate status before and in early pregnancy results in an elevated risk of neural tube defects (NTD). The evidence on the association of folate status with other health outcomes is largely fragmented and understudied. We conducted a series of umbrella reviews examining the association between folate and multiple health outcomes in various populations and settings.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, CINAHL, the Cochrane Library, and DARE from inception to February 2024 for systematic reviews with or without meta-analyses examining an association between folate intake/status and any health outcome. We performed screening and data extraction in duplicate and assessed the risk of bias using the ROBIS tool. Evidence was then characterised into unique associations (unique exposure measure - unique outcome measure - unique setting). For each category of unique associations, we identified the evidence based on the statistical power, recency of publication and the potential risk of bias. All unique associations were evaluated for credibility using predefined criteria.</p><p><strong>Results: </strong>We retrieved 3565 records and included 283 in the final synthesis. The evidence on anaemia consisted of four intervention trials demonstrating effectiveness of folic acid supplementation during pregnancy in reducing the risk of megaloblastic anaemia (relative risk (RR) = 0.21; 95% CI = 0.11, 0.38; I<sup>2</sup> = 15%). Maternal folic acid use was also significantly inversely related to the prevention of NTD at birth (RR = 0.31; 95% CI = 0.16, 0.60; I<sup>2</sup> = 0%) and NTD recurrence (RR = 0.30; 95% CI = 0.14, 0.65; I<sup>2</sup> = 0%). This relationship was supported by the inverse association reported between low maternal blood folate concentrations and the increased risk of NTD. Further evidence showed that fortification of food with folic acid was associated with the lower prevalence of NTD on a population-level.</p><p><strong>Conclusion: </strong>In NTDs and anaemia, we identified strong evidence supporting the protective role of folate status based on intervention trials and observational studies. More recent reviews examining the role of folate in other less well understood health conditions will be presented in the subsequent reports.</p><p><strong>Registration: </strong>PROSPERO: CRD42021265041.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04014"},"PeriodicalIF":4.3,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12856383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mei Yang, Yuxuan Zhu, Lin Liu, Chuanliang Pan, Lifen Li, Qingqing Su, Wenwen Zhou, Linxi Fu, Lin Yang, Fengming Luo, Lei Chen
Background: High altitude polycythaemia (HAPC) has posed a major burden due to its high prevalence and multisystem involvement among highlanders, but clinical data on HAPC is scarce. We aimed to describe the clinical characteristics of patients with HAPC in China.
Methods: Adult patients diagnosed with HAPC in five hospitals of China between August 2012 to May 2024 were retrospectively enrolled. We analysed information including demographics, living altitude, haemoglobin concentration (Hb) and comorbidities, and fitted restricted cubic splines models with multivariable adjustments to investigate the relationship between age, altitude and Hb.
Results: A total of 1098 HAPC patients were included and 97 individuals of them did not provide information on ethnicity. Of the remaining 1001 participants, 93% were native Tibetans. The median Hb showed a significant difference (P < 0.0001) between male (21.9 g/dL, interquartile range (IQR) = 21.4-22.9 g/dL) and female patients (19.6 g/dL, IQR = 19.2-20.8 g/dL), and was slightly higher in Tibetans than Han migrants, especially in females (19.6 g/dL, IQR = 19.2-20.7 g/dL vs. 19.3 g/dL, IQR = 19.2-19.5 g/dL) (P = 0.198). Restricted cubic splines models revealed Hb exhibited a positive linear correlation with altitude (P-overall = 0.027, P-nonlinear = 0.291), with a rate of 0.3g/dL/1000 m of elevation, whereas no significant relationship with age (P-overall = 0.974, P-nonlinear = 0.860). The commonest comorbidities were hypertension (18.5%) and pneumonia (17.6%). Besides, heart failure (P < 0.001), chronic airway disease (P = 0.018) and pulmonary heart disease (P < 0.001) were more prominent in females while liver disease (P = 0.079) was more frequent in males.
Conclusions: This study suggests a much higher proportion of HAPC in native Tibetans, and the Hb in HAPC patients remains significant gender-specific and altitude-dependent variations. Moreover, in addition to hypertension and pneumonia, gender-specific comorbidity surveillance should pay attention to digestive system disease in male HAPC patients and cardiopulmonary system disease in female HAPC patients.
{"title":"Demographics, clinical features, and comorbidities of high-altitude polycythaemia: a multicentre, retrospective, observational study.","authors":"Mei Yang, Yuxuan Zhu, Lin Liu, Chuanliang Pan, Lifen Li, Qingqing Su, Wenwen Zhou, Linxi Fu, Lin Yang, Fengming Luo, Lei Chen","doi":"10.7189/jogh.16.04042","DOIUrl":"10.7189/jogh.16.04042","url":null,"abstract":"<p><strong>Background: </strong>High altitude polycythaemia (HAPC) has posed a major burden due to its high prevalence and multisystem involvement among highlanders, but clinical data on HAPC is scarce. We aimed to describe the clinical characteristics of patients with HAPC in China.</p><p><strong>Methods: </strong>Adult patients diagnosed with HAPC in five hospitals of China between August 2012 to May 2024 were retrospectively enrolled. We analysed information including demographics, living altitude, haemoglobin concentration (Hb) and comorbidities, and fitted restricted cubic splines models with multivariable adjustments to investigate the relationship between age, altitude and Hb.</p><p><strong>Results: </strong>A total of 1098 HAPC patients were included and 97 individuals of them did not provide information on ethnicity. Of the remaining 1001 participants, 93% were native Tibetans. The median Hb showed a significant difference (P < 0.0001) between male (21.9 g/dL, interquartile range (IQR) = 21.4-22.9 g/dL) and female patients (19.6 g/dL, IQR = 19.2-20.8 g/dL), and was slightly higher in Tibetans than Han migrants, especially in females (19.6 g/dL, IQR = 19.2-20.7 g/dL vs. 19.3 g/dL, IQR = 19.2-19.5 g/dL) (P = 0.198). Restricted cubic splines models revealed Hb exhibited a positive linear correlation with altitude (P-overall = 0.027, P-nonlinear = 0.291), with a rate of 0.3g/dL/1000 m of elevation, whereas no significant relationship with age (P-overall = 0.974, P-nonlinear = 0.860). The commonest comorbidities were hypertension (18.5%) and pneumonia (17.6%). Besides, heart failure (P < 0.001), chronic airway disease (P = 0.018) and pulmonary heart disease (P < 0.001) were more prominent in females while liver disease (P = 0.079) was more frequent in males.</p><p><strong>Conclusions: </strong>This study suggests a much higher proportion of HAPC in native Tibetans, and the Hb in HAPC patients remains significant gender-specific and altitude-dependent variations. Moreover, in addition to hypertension and pneumonia, gender-specific comorbidity surveillance should pay attention to digestive system disease in male HAPC patients and cardiopulmonary system disease in female HAPC patients.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"16 ","pages":"04042"},"PeriodicalIF":4.3,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12856962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}